• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/19

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

19 Cards in this Set

  • Front
  • Back
Acute promyelocytic leukemia (APL)
Tretinoin
As2O3
Chronic Mylogenous Leukemia (CML)
Imatinib (Ph+)
Acute Lymphocytic Leukemia (ALL)
Imatinib (Ph+)
Asparaginase
Leukemia
Glucocorticoids
Aminopterin
Tretinoin
Imatinib (Ph+)
AIDS-related Kaposi's sarcoma
Alitretinoin
Cutaneous T cell lymphoma
Bexarotene
Vorinostat
Romidepsin
Denileukin
Breast Cancer
Tamoxifen
Trastuzumab
Lapatinib
Fulvestrant (tamoxifen-resistant)
Letrozole
Melanoma
Vemurafenib (late-stage melanoma)
IL-2 (malignant melanoma)
Levamisole (withdrawn from market)
Ipilimumab
Gastrointestinal stromal tumors (GIST)
Imatinib (cKit target)
Bevacizumab (imatinib resistant GIST)
NSCLC
Erlotinib
Gefitinib
Bevacizumab
squamous cell carcinoma
Cetuximab (absence of K-Ras mut)
colon cancer
Cetuximab (absence of K-Ras mut)
Levamisole (withdrawn from market)
metastatic colorectal cancer
Bevacizumab
Renal cell carcinoma (RCC)
Bevacizumab
Sorafenib
IL-2
IFN-α 2a
IFN-γ
Unresectable hepatocellular carcinoma
Sorafenib
Multiple myeloma
Bortezomib
Myelodysplastic syndrome
Azacitidine
5-Aza-2'-deoxycytidine (Decitabine)
Prostate cancer
Provenge (metastatic, castration-resistant prostate cancer)
Flutamide
metastatic carcinoma of ovary
Topotecan